The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Trastuzumab deruxtecan

Australian Public Assessment Report

AusPAR

AusPAR: Trastuzumab deruxtecan [PDF, 1.12 MB]

AusPAR: Trastuzumab deruxtecan [Word, 1.5 MB]

Attachment: Product information for Trastuzumab deruxtecan [PDF, 244.55 KB]

Attachment: Product information for Trastuzumab deruxtecan [Word, 131.85 KB]

Device/Product Name

Enhertu

Active ingredients

Trastuzumab deruxtecan

AusPAR Date

15 June 2022

Published

27 June 2022

Submission Number

PM-2020-04659-1-4

Submission Type

New biological entity

Decision

Approved for provisional registration